Skip to main content
MedPathMedPath Home
Clinical Trials/ITMCTR2000003144
ITMCTR2000003144
Not yet recruiting
未知

Clinical Research on Treatment of COVID-19 (mild and moderate cases) with Toujiequwen Granules

Guangzhou Eighth People's Hospital0 sitesTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCOVID-19

Overview

Phase
未知
Intervention
Not specified
Conditions
COVID-19
Sponsor
Guangzhou Eighth People's Hospital
Status
Not yet recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Guangzhou Eighth People's Hospital

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients who have been diagnosed as COVID\-19 according to The Diagnosis and Treatment Plan for 2019\-nCoV(The Fifth Trial Edition);
  • •2\. aged between 18 to 80 years old, male or female;
  • •3\. the subjects participating the clinical trial are voluntary and sign the informed consent, thoroughly informed the purpose, method, possible reaction.

Exclusion Criteria

  • •1\. Patients who are difficult to be administered orally or by nasal feeding, those who are allergic to the test drug and those who are intolerant to the drug;
  • •2\. The compliance of medication cannot be guaranteed during the treatment
  • •3\. Patients with severe primary respiratory diseases, or pneumonia caused by other pathogen.
  • •4\. Patients with serious diseases, malignant tumors or mental diseases;
  • •5\. Pregnant women, urine pregnancy test positive;
  • •6\. Participated in other drug trials in the past month;
  • •7\. The investigator judged that the patient was not suitable for the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Ozone Therapy for Covid 19 patientsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2020/07/026671Bisleri charitable trust
Not yet recruiting
Not Applicable
Epidemiology and outcomes of COVID-19 in Udupi
CTRI/2020/07/026472Kasturba Medical College Manipal
Active, not recruiting
Not Applicable
HS COVID-related post-traumatic stress disorder (PTSD) experimental treatment trialPost-Traumatic Stress Disorder (PTSD)Mental and Behavioural Disorders
ISRCTN52834682King's College London18
Active, not recruiting
Phase 1
RANDOMISED EVALUATION OF COVID-19 THERAPY (RECOVERY)COVID-19 (infection with SARS-CoV-2 virus)MedDRA version: 21.1Level: PTClassification code 10035737Term: Pneumonia viralSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.1Level: PTClassification code 10061982Term: Severe acute respiratory syndromeSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Virus Diseases [C02]
EUCTR2020-001113-21-GBniversity of Oxford20,000
Active, not recruiting
Phase 1
Cure COVID: A study to compare the efficacy of GNS561 versus standard treatments in patients with SARS-CoV-2 (COVID-19) infection.COVID-19 infectionMedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Virus Diseases [C02]
EUCTR2020-002249-40-BGGenoscience Pharma120